These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 17334522)
1. Perioperative bridging with fondaparinux in a woman with antithrombin deficiency. Bauersachs R; Alban S Thromb Haemost; 2007 Mar; 97(3):498-9. PubMed ID: 17334522 [No Abstract] [Full Text] [Related]
2. Treatment of venous thromboembolism: duration and new options. Huisman MV Hematol J; 2004; 5 Suppl 3():S24-8. PubMed ID: 15190273 [No Abstract] [Full Text] [Related]
3. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Agnelli G; Bergqvist D; Cohen AT; Gallus AS; Gent M; Br J Surg; 2005 Oct; 92(10):1212-20. PubMed ID: 16175516 [TBL] [Abstract][Full Text] [Related]
4. The safety of fondaparinux for the prevention and treatment of venous thromboembolism. Turpie AG Expert Opin Drug Saf; 2005 Jul; 4(4):707-21. PubMed ID: 16011449 [TBL] [Abstract][Full Text] [Related]
5. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. Krishnan JA; Streiff MB N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879888 [No Abstract] [Full Text] [Related]
6. Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery. Bergqvist D Vasc Health Risk Manag; 2006; 2(4):365-70. PubMed ID: 17323590 [TBL] [Abstract][Full Text] [Related]
7. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study. Hammerstingl C; Omran H; Tripp C; Poetzsch B Thromb Haemost; 2009 Feb; 101(2):325-32. PubMed ID: 19190817 [TBL] [Abstract][Full Text] [Related]
8. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123 [TBL] [Abstract][Full Text] [Related]
9. [DO's and DON'Ts: Perioperative management with vitamin-K-independent anticoagulants]. Koscielny J Dtsch Med Wochenschr; 2015 Jun; 140 Suppl 1():S15-7. PubMed ID: 26069040 [No Abstract] [Full Text] [Related]
10. Use of neuraxial anesthesia with selective factor Xa inhibitors. Cannavo D Am J Orthop (Belle Mead NJ); 2002 Nov; 31(11 Suppl):21-3. PubMed ID: 12463580 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulating obese patients in the modern era. Patel JP; Roberts LN; Arya R Br J Haematol; 2011 Oct; 155(2):137-49. PubMed ID: 21848880 [TBL] [Abstract][Full Text] [Related]
12. [Fondaparinux -- mechanism of action, and effective and broad range of indications]. Bauersachs RM Vasa; 2015 Mar; 44(2):138-9. PubMed ID: 25881373 [No Abstract] [Full Text] [Related]
14. [Summary and perspectives. Rivaroxaban]. Albaladejo P Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S28-31. PubMed ID: 19185785 [TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulants--the old and the new. Ansell J Dis Mon; 2005; 51(2-3):208-12. PubMed ID: 15900274 [No Abstract] [Full Text] [Related]
16. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Gerhardt A; Zotz RB; Stockschlaeder M; Scharf RE Thromb Haemost; 2007 Mar; 97(3):496-7. PubMed ID: 17334521 [No Abstract] [Full Text] [Related]
17. [Prevention of venous thromboembolism in orthopedic surgery and traumatology]. Agnelli G; Cimminiello C Recenti Prog Med; 2007 Jan; 98 Suppl 1():25S-32S. PubMed ID: 17455706 [No Abstract] [Full Text] [Related]
18. [From apixaban to aspirin in the prevention of recurrent venous thromboembolism]. Diez-Ewald M Invest Clin; 2013 Sep; 54(3):231-3. PubMed ID: 24354237 [TBL] [Abstract][Full Text] [Related]